Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

144
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
144
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

4.2K
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
4.2K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

103
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
103
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

118
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
118
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

77
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
77
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.5K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are We Heading into a Dead End, or Are We Treading Water?

Toxins·2026
Same author

Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin Therapy.

Toxins·2026
Same author

How to treat cardiovascular autonomic failure in Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

The diagnosis comes before therapy, even with non-motor features.

Therapeutic advances in neurological disorders·2025
Same author

Botulinum Toxin: Previous Developments, Current Status, and Perspectives.

Toxins·2025
Same author

Approaches for treating cardiovascular symptoms in Parkinson's disease.

Therapeutic advances in neurological disorders·2025

Related Experiment Video

Updated: Dec 5, 2025

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
05:02

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

33.1K

Is It Meanwhile Biomedical Sciences or Still "Ars Medica"?

Wolfgang H Jost1

  • 1Parkinson-Klinik Ortenau, Center for Movement Disorders, 77709 Wolfach, Germany.

Cells
|October 21, 2020
PubMed
Summary

Scientific research is demanding and often frustrating. This study explores methods to streamline the scientific process, aiming to improve efficiency and reduce common obstacles for researchers.

Area of Science:

  • This research falls within the field of scientific methodology and research management.

Background:

  • Scientific endeavors are characterized by significant time investments and inherent challenges.
  • The process of scientific discovery often involves overcoming numerous obstacles and setbacks.

Discussion:

  • Exploring strategies to mitigate common frustrations in scientific research.
  • Analyzing the impact of time-intensive processes on research productivity.
  • Identifying potential solutions to enhance the efficiency of scientific workflows.

Key Insights:

  • Implementing streamlined workflows can significantly reduce research time.
  • Addressing researcher frustrations is crucial for sustained scientific progress.
  • Optimizing resource allocation can lead to more efficient scientific outcomes.

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.4K
Direct Comparison of Hyperspectral Stimulated Raman Scattering and Coherent Anti-Stokes Raman Scattering Microscopy for Chemical Imaging
09:46

Direct Comparison of Hyperspectral Stimulated Raman Scattering and Coherent Anti-Stokes Raman Scattering Microscopy for Chemical Imaging

Published on: April 28, 2022

4.5K

Related Experiment Videos

Last Updated: Dec 5, 2025

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
05:02

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

33.1K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.4K
Direct Comparison of Hyperspectral Stimulated Raman Scattering and Coherent Anti-Stokes Raman Scattering Microscopy for Chemical Imaging
09:46

Direct Comparison of Hyperspectral Stimulated Raman Scattering and Coherent Anti-Stokes Raman Scattering Microscopy for Chemical Imaging

Published on: April 28, 2022

4.5K

Outlook:

  • Future research should focus on developing practical tools for scientific process optimization.
  • Encouraging interdisciplinary collaboration can help overcome research bottlenecks.
  • Fostering a supportive research environment is essential for long-term scientific advancement.